查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2026754

電腦輔助檢測 (CAD) 市場預測至 2034 年—按產品類型、適應症、應用、最終用戶和地區分類的全球分析

Computer Aided Detection Market Forecasts to 2034 - Global Analysis By Product Type, Indication, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球電腦輔助偵測 (CAD) 市場規模將達到 10.276 億美元，在預測期內以 7.9% 的複合年成長率成長，到 2034 年將達到 18.879 億美元。

電腦輔助檢測（CAD）是一套利用模式辨識幫助醫師解讀醫學影像的演算法。 CAD軟體透過X光、磁振造影、超音波影像和電腦斷層掃描（CT）等影像技術，輔助診斷包括冠狀動脈疾病、癌症、心血管疾病和神經系統疾病在內的多種疾病。

根據世界衛生組織（世衛組織）的估計，到 2022 年，癌症將成為全球首要死因，2020 年約有 1,000 萬人死於癌症，約佔死亡總數的六分之一。

對疾病早期檢測的需求日益成長

疾病的早​​期發現對於提高治療成功率和改善患者預後至關重要。電腦輔助診斷（CAD）系統與影像技術相結合，能夠分析影像並突出顯示潛在問題區域，從而輔助放射科醫生進行疾病的早期發現。此外，癌症、心血管疾病和神經系統疾病等慢性疾病的日益普遍，也使得早期診斷的需求不斷成長。因此，對疾病早期發現日益成長的需求是推動市場需求的關鍵因素。

高昂的實施成本

高昂的實施成本是電腦輔助偵測（CAD）系統在市場上普及的主要障礙。實施CAD系統需要大量投資，包括採集費用，以及培訓醫療專業人員的成本。 CAD軟體，尤其是針對特定醫學專科或影像技術設計的軟體，價格可能非常昂貴。此外，支援CAD系統的硬體需求，例如高效能電腦和儲存解決方案，也會增加整體實施成本。

醫學影像技術的發展

電腦斷層掃描（CT）、磁振造影（MRI）和乳房X光攝影等醫學影像技術的不斷發展，為更先進、更精細的診斷能力鋪平了道路。這些進步不僅提高了醫學影像的質量，也為電腦輔助診斷（CAD）系統檢測細微異常創造了機會，從而輔助醫療專業人員做出準確診斷。醫學影像技術的創新正在加速市場擴張。

資料隱私

電腦輔助診斷（CAD）的實施涉及高度敏感的患者資料的處理和存儲，包括醫學影像和相關健康記錄。隨著CAD系統分析和解讀這些訊息，人們對潛在資料外洩和未授權存取的擔憂日益加劇。維護病患資料的隱私和安全對於遵守醫療保健法規以及建立病患與醫療服務提供者之間的信任至關重要。因此，資料隱私是一個主要問題，也是阻礙市場需求的因素。

新冠疫情的感染疾病

疫情期間，人們對醫療保健和診斷的關注度顯著提高，凸顯了電腦輔助診斷（CAD）等先進技術在疾病檢測和監測中的重要性。對更精準、更有效率的診斷工具的需求不斷成長，推動了人們對能夠輔助解讀醫學影像的CAD解決方案的興趣，尤其是在新冠肺炎等呼吸系統疾病的診療方面。然而，疫情也為CAD市場帶來了挑戰。醫療機構的財政壓力以及供應鏈中斷，都影響了CAD系統的應用。

在預測期內，磁振造影（MRI）細分市場預計將是最大的。

磁振造影（MRI）領域預計將佔據最大佔有率。在電腦輔助檢測（CAD）中，MRI 在提高影像分析的準確性和效率方面發揮著至關重要的作用。 CAD 系統利用 MRI 產生的詳細影像來識別可能提示疾病或病症的潛在異常和可疑模式。此外，MRI 和 CAD 技術的整合能夠提高檢測率、減少假陽性，並全面提升診斷準確性。

預計在預測期內，腫瘤治療領域將呈現最高的複合年成長率。

預計在預測期內，腫瘤學領域將顯著成長。電腦輔助診斷（CAD）技術在腫瘤學領域發揮變革性作用，它透過分析醫學影像數據，幫助醫療專業人員早期發現和鑑別癌症病灶。在乳房X光檢查、 電腦斷層掃描和MRI等影像技術中，CAD系統利用先進的演算法來識別細微的異常、潛在的腫瘤以及可能提示癌症的組織結構不規則之處。

市佔率最大的地區：

在預測期內，亞太地區佔據了最大的市場佔有率。由於人們對早期疾病檢測益處的認知不斷提高，以及癌症等疾病發病率的上升，該地區對電腦輔助診斷（CAD）解決方案的需求正在激增。亞太地區各國政府正大力投資醫療現代化，為CAD市場的擴張創造了有利環境。此外，在人口眾多、疾病負擔沉重的國家，例如中國和印度，CAD系統因其能夠提高診斷的準確性和效率而備受關注。

複合年成長率最高的地區：

在北美，完善的醫療保健基礎設施和慢性病的高發生率使得電腦輔助診斷（CAD）成為診斷流程中的關鍵組成部分，預計在預測期內將實現盈利成長。美國尤其憑藉其在研發方面的巨額投資、成熟的醫療保健體係以及積極整合最尖端科技的舉措，正在引領北美CAD市場的發展。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場公司（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球電腦輔助偵測 (CAD) 市場：依產品類型分類

  • 腹部冠狀動脈疾病
  • 攝護腺冠狀動脈疾病
  • 乳房電腦輔助設計
  • 心血管冠狀動脈疾病
  • 其他產品類型

第6章：全球電腦輔助偵測（CAD）市場：依適應症分類

  • 超音波檢查
  • X光影像診斷
  • 磁振造影
  • 電腦斷層掃描
  • 核醫學影像
  • 乳房X光檢查
  • 其他改編

第7章 全球電腦輔助偵測 (CAD) 市場：依應用分類

  • 腫瘤學
    • 結腸癌
    • 乳癌
    • 攝護腺癌
    • 肺癌
    • 骨癌
    • 肝癌
  • 心血管和神經系統癌症

第8章：全球電腦輔助偵測（CAD）市場：依最終使用者分類

  • 診斷中心
  • 醫院
  • 其他最終用戶

第9章 全球電腦輔助偵測（CAD）市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第10章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第11章：公司簡介

  • Hologic, Inc
  • CANON Medical Systems Corporation
  • EDDA Technology, Inc
  • Koninklijke Philips NV
  • Siemens
  • FUJIFILM Holdings Corporation
  • NANO-X Imaging LTD.
  • General Electric
  • IBM
  • Riverain Technologies
  • iCAD Inc
  • Median Technologies
  • Carestream Health
  • Shimadzu Analytical（India）Pvt. Ltd
  • Karyopharm
Product Code: SMRC24740

According to Stratistics MRC, the Global Computer Aided Detection Market is accounted for $1027.6 million in 2026 and is expected to reach $1887.9 million by 2034 growing at a CAGR of 7.9% during the forecast period. Computer-aided detection (CAD) is a collection of algorithms that use pattern recognition to help physicians interpret medical images. The computer-aided detection software aids in the diagnosis of various diseases, including coronary artery disease, cancer, cardiovascular diseases, and neurological diseases, through imaging modalities such as x-ray imaging, magnetic resonance imaging, ultrasound imaging, and computed tomography.

According to the World Health Organization (WHO) estimates, in 2022, cancer is the leading cause of death worldwide, resulting in approximately 10 million deaths in 2020, or nearly one in six deaths.

Market Dynamics:

Driver:

Rising demand for early disease detection

Early detection of diseases is crucial, as it enhances the chances of successful treatment and improves patient outcomes. CAD systems integrated with imaging modalities analyze the images and highlight potential areas of concern, aiding radiologists in the early detection of diseases. Moreover, the rising prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders has heightened the need for early diagnosis. Therefore, growing demand for early disease detection is a significant driver accelerating market demand.

Restraint:

High implementation costs

High implementation costs pose a significant restraint to the adoption of computer-aided detection (CAD) systems on the market. Implementing CAD systems requires substantial investment, which includes the cost of acquiring the software, hardware infrastructure, and training of healthcare professionals. CAD software itself can be expensive, especially if it is designed for specific medical specialties or imaging modalities. Additionally, the hardware requirements to support CAD systems, such as high-performance computers and storage solutions, can add to the overall implementation costs.

Opportunity:

Evolution of medical imaging technologies

The continuous evolution of medical imaging technologies, such as computed tomography (CT), magnetic resonance imaging (MRI), and mammography, has paved the way for more sophisticated and detailed diagnostic capabilities. These advancements not only enhance the quality of medical imaging but also create opportunities for CAD systems to excel in their ability to detect subtle abnormalities and assist healthcare professionals in making accurate diagnoses. These innovations in medical imaging technologies accelerate market expansion.

Threat:

Data privacy

The implementation of CAD involves the processing and storage of sensitive patient data, including medical images and associated health records. As CAD systems analyze and interpret this information, there is a heightened concern for potential breaches and unauthorized access. Maintaining the privacy and security of patient data is crucial to complying with healthcare regulations and building trust among patients and healthcare providers. Therefore, data privacy is a significant concern, hindering market demand.

Covid-19 Impact

The increased focus on healthcare and diagnostics during the pandemic has underscored the importance of advanced technologies like CAD in detecting and monitoring diseases. The demand for more accurate and efficient diagnostic tools has risen, driving interest in CAD solutions that can aid in the interpretation of medical images, especially in the context of respiratory illnesses such as COVID-19. However, the pandemic has also presented challenges for the CAD market. Financial constraints on healthcare facilities, coupled with disruptions in the supply chain, have affected the adoption of CAD systems.

The nuclear resonance imaging segment is expected to be the largest during the forecast period

The nuclear resonance imaging segment is estimated to hold the largest share. In computer-aided detection, nuclear resonance imaging plays a significant role in enhancing the accuracy and efficiency of image analysis. CAD systems utilize the detailed images generated by nuclear resonance imaging to identify potential abnormalities or suspicious patterns that may indicate the presence of a disease or condition. Moreover, the integration of NRI with CAD technology has led to improved detection rates, reduced false positives, and enhanced overall diagnostic accuracy.

The oncology segment is expected to have the highest CAGR during the forecast period

The oncology segment is anticipated to have lucrative growth during the forecast period. CAD technologies play a transformative role in oncology by aiding healthcare professionals in the early detection and characterization of cancerous lesions through the analysis of medical imaging data. In modalities like mammography, CT scans, and MRI, CAD systems utilize advanced algorithms to identify subtle abnormalities, potential tumours, and irregularities in tissue structures that may be indicative of cancer.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period. The demand for CAD solutions in this region is escalating due to increasing awareness of the benefits of early disease detection and a rising prevalence of diseases like cancer. Governments across Asia-Pacific are investing significantly in healthcare modernization, fostering an environment conducive to CAD market expansion. Additionally, in countries like China and India, where large populations contribute to a high disease burden, CAD systems are gaining traction for their role in improving diagnostic accuracy and efficiency.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period, owing to robust healthcare infrastructure, coupled with a high prevalence of chronic diseases, positions CAD as a crucial component in diagnostic workflows. The United States, in particular, dominates the North American CAD market, owing to substantial investments in research and development, a well-established healthcare sector, and a proactive approach to integrating cutting-edge technologies.

Key players in the market

Some of the key players in the Computer Aided Detection Market include Hologic Inc, CANON Medical Systems Corporation, EDDA Technology, Inc, Koninklijke Philips N.V, Siemens, FUJIFILM Holdings Corporation, NANO-X Imaging LTD., General Electric, IBM, Riverain Technologies, iCAD Inc, Median Technologies, Carestream Health, Shimadzu Analytical (India) Pvt. Ltd and Karyopharm.

Key Developments:

In October 2023, Hologic, Inc., a global leader in women's health, announced an innovative new partnership with the American Association of Gynecologic Laparoscopists (AAGL) and Inovus Medical.

In October 2023, Hologic, Inc., a global leader in women's health, announced an innovative new partnership with the American Association of Gynecologic Laparoscopists (AAGL) and Inovus Medical. Hologic becomes the chief provider of hystero scopes for AAGL's Essentials in Minimally Invasive Gynecologic Surgery (EMIGS) hands-on hysteroscopy skills training for OB-GYN residents.

Product Types Covered:

  • Abdominal CAD
  • Prostrate CAD
  • Breast CAD
  • Cardiovascular CAD
  • Other Product Types

Indications Covered:

  • Ultrasound Resonance Imaging
  • X-ray Imaging
  • Magnetic Resonance Imaging
  • Computed Tomography
  • Nuclear Resonance Imaging
  • Mammography
  • Other Indications

Applications Covered:

  • Oncology
  • Cardiovascular and Neurological Cancer

End Users Covered:

  • Diagnostic Centers
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Computer Aided Detection Market, By Product Type

  • 5.1 Introduction
  • 5.2 Abdominal CAD
  • 5.3 Prostrate CAD
  • 5.4 Breast CAD
  • 5.5 Cardiovascular CAD
  • 5.6 Other Product Types

6 Global Computer Aided Detection Market, By Indication

  • 6.1 Introduction
  • 6.2 Ultrasound Resonance Imaging
  • 6.3 X-ray Imaging
  • 6.4 Magnetic Resonance Imaging
  • 6.5 Computed Tomography
  • 6.6 Nuclear Resonance Imaging
  • 6.7 Mammography
  • 6.8 Other Indications

7 Global Computer Aided Detection Market, By Application

  • 7.1 Introduction
  • 7.2 Oncology
    • 7.2.1 Colorectal Cancer
    • 7.2.2 Breast Cancer
    • 7.2.3 Prostate Cancer
    • 7.2.4 Lung Cancer
    • 7.2.5 Bone Cancer
    • 7.2.6 Liver Cancer
  • 7.3 Cardiovascular and Neurological Cancer

8 Global Computer Aided Detection Market, By End User

  • 8.1 Introduction
  • 8.2 Diagnostic Centers
  • 8.3 Hospitals
  • 8.4 Other End Users

9 Global Computer Aided Detection Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Hologic, Inc
  • 11.2 CANON Medical Systems Corporation
  • 11.3 EDDA Technology, Inc
  • 11.4 Koninklijke Philips N.V
  • 11.5 Siemens
  • 11.6 FUJIFILM Holdings Corporation
  • 11.7 NANO-X Imaging LTD.
  • 11.8 General Electric
  • 11.9 IBM
  • 11.10 Riverain Technologies
  • 11.11 iCAD Inc
  • 11.12 Median Technologies
  • 11.13 Carestream Health
  • 11.14 Shimadzu Analytical (India) Pvt. Ltd
  • 11.15 Karyopharm

List of Tables

  • Table 1 Global Computer Aided Detection Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Computer Aided Detection Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Computer Aided Detection Market Outlook, By Abdominal CAD (2023-2034) ($MN)
  • Table 4 Global Computer Aided Detection Market Outlook, By Prostrate CAD (2023-2034) ($MN)
  • Table 5 Global Computer Aided Detection Market Outlook, By Breast CAD (2023-2034) ($MN)
  • Table 6 Global Computer Aided Detection Market Outlook, By Cardiovascular CAD (2023-2034) ($MN)
  • Table 7 Global Computer Aided Detection Market Outlook, By Other Product Types (2023-2034) ($MN)
  • Table 8 Global Computer Aided Detection Market Outlook, By Indication (2023-2034) ($MN)
  • Table 9 Global Computer Aided Detection Market Outlook, By Ultrasound Resonance Imaging (2023-2034) ($MN)
  • Table 10 Global Computer Aided Detection Market Outlook, By X-ray Imaging (2023-2034) ($MN)
  • Table 11 Global Computer Aided Detection Market Outlook, By Magnetic Resonance Imaging (2023-2034) ($MN)
  • Table 12 Global Computer Aided Detection Market Outlook, By Computed Tomography (2023-2034) ($MN)
  • Table 13 Global Computer Aided Detection Market Outlook, By Nuclear Resonance Imaging (2023-2034) ($MN)
  • Table 14 Global Computer Aided Detection Market Outlook, By Mammography (2023-2034) ($MN)
  • Table 15 Global Computer Aided Detection Market Outlook, By Other Indications (2023-2034) ($MN)
  • Table 16 Global Computer Aided Detection Market Outlook, By Application (2023-2034) ($MN)
  • Table 17 Global Computer Aided Detection Market Outlook, By Oncology (2023-2034) ($MN)
  • Table 18 Global Computer Aided Detection Market Outlook, By Colorectal Cancer (2023-2034) ($MN)
  • Table 19 Global Computer Aided Detection Market Outlook, By Breast Cancer (2023-2034) ($MN)
  • Table 20 Global Computer Aided Detection Market Outlook, By Prostate Cancer (2023-2034) ($MN)
  • Table 21 Global Computer Aided Detection Market Outlook, By Lung Cancer (2023-2034) ($MN)
  • Table 22 Global Computer Aided Detection Market Outlook, By Bone Cancer (2023-2034) ($MN)
  • Table 23 Global Computer Aided Detection Market Outlook, By Liver Cancer (2023-2034) ($MN)
  • Table 24 Global Computer Aided Detection Market Outlook, By Cardiovascular and Neurological Cancer (2023-2034) ($MN)
  • Table 25 Global Computer Aided Detection Market Outlook, By End User (2023-2034) ($MN)
  • Table 26 Global Computer Aided Detection Market Outlook, By Diagnostic Centers (2023-2034) ($MN)
  • Table 27 Global Computer Aided Detection Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 28 Global Computer Aided Detection Market Outlook, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.